Comparison of a fractional bipolar radiofrequency device and a fractional erbium-doped glass 1,550-nm device for the treatment of atrophic acne scars: a randomized split-face clinical study

Dermatol Surg. 2014 Jan;40(1):14-21. doi: 10.1111/dsu.12372. Epub 2013 Nov 25.

Abstract

Background: A fractional erbium-doped glass 1,550-nm and a fractional bipolar radiofrequency (RF) device are effective in the treatment of atrophic acne scars.

Objective: To compare the clinical effectiveness and side effects of fractional bipolar RF with those of fractional erbium-doped glass in atrophic acne scars treatment.

Materials and methods: Twenty Thai subjects with atrophic acne scars received three split-face monthly treatments, one side with fractional bipolar RF and the other with fractional erbium-doped glass. Three independent physicians and patients evaluated improvement in acne scars 4 weeks after the last treatment. Side effects were also recorded after each treatment.

Results: The study found significant improvement in acne scars after treatment with fractional bipolar RF and with a fractional erbium-doped glass device without a statistically significant difference between the two devices. The side effects of both devices were pain, transient facial erythema, and scab formation. The pain score with fractional erbium-doped glass was higher than that with fractional bipolar RF, but duration of scab shedding was shorter. One case had postinflammatory hyperpigmentation on only the side treated with fractional erbium-doped glass.

Conclusion: Fractional bipolar RF and fractional erbium-doped glass have similar effectiveness for the treatment of atrophic acne scars.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Acne Vulgaris / complications
  • Acne Vulgaris / radiotherapy*
  • Adult
  • Atrophy
  • Cicatrix / etiology
  • Cicatrix / pathology
  • Cicatrix / radiotherapy*
  • Dose Fractionation, Radiation
  • Erbium
  • Female
  • Humans
  • Lasers, Solid-State / therapeutic use*
  • Low-Level Light Therapy / instrumentation
  • Low-Level Light Therapy / methods*
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Substances

  • Erbium